However, expression of SSX2 in prostate cancer cells was not associated with a mesenchymal phenotype, and forced overexpression in different prostate cell lines resulted in no phenotypic changes and no significant EMT-associated gene changes. The gene discussed is SSX2; the disease is prostate cancer.